Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GNOM
Global X Genomics & Biotechnology ETF
55.4
1
USD
0.00%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.36%
Monthly Change
+11.51%
6 month change
+19.68%
Year Change
+19.68%
Previous Close
55.6
1
Open
55.4
1
Low
55.4
1
High
55.4
1
Volume
1
Markets
US ETFs
GNOM
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Overview
All holdings
Heatmap
Top holdings
Market Value
Shares
Weight %
A
AZN
ASTRAZENECA PLC
1.2 M
5 706.0
2.3%
BEAM
Beam Therapeutics Inc
1.2 M
40.6 K
2.2%
TXG
10X Genomics Inc
1.1 M
49.1 K
2.2%
LEGN
Legend Biotech Corp
1.1 M
59.1 K
2.1%
RARE
Ultragenyx Pharmaceutical Inc
930.4 K
39.8 K
1.8%
WGS
GeneDx Holdings Corp
898.3 K
11.3 K
1.7%
WVE
WAVE Life Sciences Ltd
786.3 K
56.4 K
1.5%
Genscript Biotech Corp
761.6 K
498.9 K
1.5%
SRPT
SAREPTA THERAPEUTICS, INC.
686.8 K
41.0 K
1.3%
NTLA
INTELLIA THERAPEUTICS, INC.
621.1 K
45.1 K
1.2%
CDNA
CAREDX, INC.
418.5 K
22.3 K
0.8%
QURE
Uniqure NV
378.9 K
24.2 K
0.7%
VIR
Vir Biotechnology Inc
364.9 K
40.1 K
0.7%
PSNL
Personalis Inc
213.5 K
23.6 K
0.4%
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
200.8 K
119.5 K
0.4%
A
AGILENT TECHNOLOGIES, INC.
200.6 K
1 653.0
0.4%
RCKT
ROCKET PHARMACEUTICALS, INC.
188.2 K
37.6 K
0.4%
PRME
Prime Medicine Inc
187.9 K
40.7 K
0.4%
RGNX
Regenxbio Inc
185.2 K
20.5 K
0.4%
MYGN
MYRIAD GENETICS, INC.
180.9 K
39.2 K
0.3%
1
2
3
News
It's Not All About AI: Where To Find Other Potential Market Opportunities
Healthcare Investing: Finding Growth Beyond Pharmaceuticals
America At 250: Built On Reinvention, Powered By Innovation
Biotech Is The Rate Cut Trade In Disguise
The Disinflation Trade Has A New Address: Genomics
Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead?
Health Care Flies High
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts